Literature DB >> 7431632

Tolmetin-induced aseptic meningitis.

G B Ruppert, W F Barth.   

Abstract

A 21-year-old woman with systemic lupus erythematosus (SLE) had meningismus, conjunctivitis, lymphadenopathy, and elevation of liver function values following ibuprofen therapy. All symptoms and laboratory value abnormalities resolved rapidly when the drug therapy was stopped. Two years later, a similar reaction occurred after taking tolmetin sodium. Fever, adenopathy, aseptic meningitis with a polymorphonuclear pleocytosis, and serum transaminase level elevations resolved rapidly after use of the drug was discontinued. The mechanism of this reaction to nonsteroidal antiinflammatory drugs in patients with SLE is not known.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7431632

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  6 in total

Review 1.  Drug-induced aseptic meningitis: diagnosis and management.

Authors:  S Jolles; W A Sewell; C Leighton
Journal:  Drug Saf       Date:  2000-03       Impact factor: 5.606

2.  Aseptic meningitis due to trimethoprim-sulfamethoxazole.

Authors:  M Biosca; M de la Figuera; F García-Bragado; G Sampol
Journal:  J Neurol Neurosurg Psychiatry       Date:  1986-03       Impact factor: 10.154

3.  Ibuprofen-induced aseptic meningitis in a previously healthy patient.

Authors:  J M Lawson; M J Grady
Journal:  West J Med       Date:  1985-09

4.  CNS Adverse Effects of Nonsteroidal Anti-Inflammatory Drugs : Therapeutic Implications.

Authors:  A Morgan; D Clark
Journal:  CNS Drugs       Date:  1998-04       Impact factor: 5.749

5.  Ibuprofen-induced meningitis in mixed connective tissue disease.

Authors:  M Hoffman; R G Gray
Journal:  Clin Rheumatol       Date:  1982-06       Impact factor: 2.980

6.  Aseptic meningitis associated with chronic sulindac use for osteoarthritis: a case report.

Authors:  Erin C Callen; Chelsea O Church; Manish Patel; Tiffany L Sikes
Journal:  Rheumatol Int       Date:  2007-08-17       Impact factor: 2.631

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.